Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.drudis.2013.10.018 http://scihub22266oqcxt.onion/10.1016/j.drudis.2013.10.018 C4004703!4004703!24184433     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Drug+Discov+Today 2014 ; 19 (4): 469-73 Nephropedia Template TP {{tp|p=24184433|t=2014. DREADDs: novel tools for drug discovery and development |pdf=|usr=}}{{24184433}} gab.com Text DREADDs: novel tools for drug discovery and development JO: Drug Discov Today http://www.kidney.de/pget.php?&tw=1&pmid=24184433 #FOAvip Since the invention of the first designer receptors exclusively activated by designer drugs (DREADDs), these engineered G protein-coupled receptors (GPCRs) have been widely applied in investigations of biological processes and behaviors. DREADD technology has emerged as a powerful tool with great potential for drug discovery and development. DREADDs can facilitate the identification of druggable targets and enable researchers to explore the activities of novel drugs against both known and orphan GPCRs. Here, we discuss how DREADDs can be used as novel tools for drug discovery and development. Twit Text FOAVip DREADDs: novel tools for drug discovery and development ????Drug Discov Today http://www.kidney.de/pget.php?&tw=1&pmid=24184433 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24184433 #FOAvip English Wikipedia <ref>{{Cite pmid|24184433}}</ref> DREADDs: novel tools for drug discovery and development #MMPMID24184433 Lee HM; Giguere PM; Roth BL Drug Discov Today 2014[Apr]; 19 (4): 469-73 PMID24184433show ga Since the invention of the first designer receptors exclusively activated by designer drugs (DREADDs), these engineered G protein-coupled receptors (GPCRs) have been widely applied in investigations of biological processes and behaviors. DREADD technology has emerged as a powerful tool with great potential for drug discovery and development. DREADDs can facilitate the identification of druggable targets and enable researchers to explore the activities of novel drugs against both known and orphan GPCRs. Here, we discuss how DREADDs can be used as novel tools for drug discovery and development. äDREADDs: novel tools for drug discovery and development (epmc).pdf DeepDyve Pubget Overpricing